NASDAQ: GNLX
Genelux Corp Stock Ownership - Who owns Genelux?

Insider buying vs selling

Have Genelux Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph CappelloCTO2026-08-04653$2.95
$1.92kSell
Thomas ZindrickCEO;Pres2026-08-043,023$2.95
$8.91kSell
Yong YuCSci2026-08-04653$2.94
$1.92kSell
John W. SmitherDirector2026-07-0112,000$2.91
$34.90kSell
Ralph SmallingHead of Regulatory2026-06-03192$2.93
$562.56Sell
John ThomasDirector2026-06-0110,000$2.98
$29.80kSell
Yong YuChief Scientific Officer2026-05-11605$2.97
$1.80kSell
Joseph CappelloChief Technical Officer2026-05-11605$2.97
$1.80kSell
Thomas ZindrickPresident and CEO2026-05-112,798$2.94
$8.23kSell
Ralph SmallingHead of Regulatory2026-05-11270$2.98
$804.60Sell

1 of 3

GNLX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GNLX insiders and whales buy or sell their stock.

GNLX Shareholders

What type of owners hold Genelux Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Woodward Diversified Capital LLC4.72%2,117,183$5.97MInstitution
Vanguard Capital Management LLC3.78%1,695,480$4.78MInstitution
Thomas Zindrick3.26%1,460,890$4.12MInsider
Bleichroeder LP3.08%1,380,666$3.89MInstitution
Aladar Szalay1.24%555,000$1.57MInsider
John Thomas1.12%501,193$1.41MInsider
Geode Capital Management LLC1.01%453,761$1.28MInstitution
Blackrock Inc0.91%405,872$1.14MInstitution
Joseph Cappello0.73%328,737$927.04kInsider
Bank Of America Corp0.72%323,865$913.30kInstitution

1 of 3

GNLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GNLX20.72%9.91%Net SellingNet Selling
NRXP11.01%88.99%
ANIX14.96%80.46%Net BuyingNet Buying
GUTS45.39%18.44%Net BuyingNet Buying
CUE76.37%23.63%Net Buying

Genelux Stock Ownership FAQ

Who owns Genelux?

Genelux (NASDAQ: GNLX) is owned by 20.72% institutional shareholders, 9.91% Genelux insiders, and 69.37% retail investors. Thomas Zindrick is the largest individual Genelux shareholder, owning 1.46M shares representing 3.26% of the company. Thomas Zindrick's Genelux shares are currently valued at $3.67M.

If you're new to stock investing, here's how to buy Genelux stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.